In the News
Kaleido insulin pump PDF Print E-mail

Coming in the not too distant future - Kaleido insulin pump

http://www.hellokaleido.com/Kaleido is insulin pump therapy for those who don’t believe in boring. Check out their brand new website, what do you think?  #letsinjectsomecolour

Kaleido say: 'We know how essential it is to have an insulin pump system that you can trust, but we’ve heard rumbles that some of you are looking for all that and a bit more.

Kaleidoers are a fun-loving, fast moving and most importantly, a super eclectic bunch. And hey, that’s cool – variety is the spice of life, right? You want your pump to look good – you wear it everyday, after all! – and you need it to slide into your lifestyle and have your back, no questions asked.'

Read more: www.hellokaleido.com

Follow them on Twitter @HeyKaleido #letsinjectsomecolour 

e-max.it: your social media marketing partner
 
Dexcom G5 PDF Print E-mail

NEW! Make Treatment Decisions with Dexcom G5® Mobile Continuous Glucose Monitoring System!

g51CGM unveils what no meter can. While meters give a number for a single point in time, CGM provides dynamic glucose information by showing where your glucose is, where it’s going, and how fast it’s getting there. Better yet, with Dexcom G5 Mobile, you can eliminate the need for confirmatory fingersticks, for daily glucose management decisions.*

More news as it comes.... 

Expected availability late Septemeber 2015

 www.dexcom.com/en-GB

 

* A minimum of 2 fingersticks a day is still required for calibration. System may require more.

e-max.it: your social media marketing partner
 
CSII users face almost 50% less risk of heart disease PDF Print E-mail

Paradigms Revel All Colors

Insulin pump reduces mortality from cardiovascular disease by almost 50%

People with type 1 diabetes who use insulin pump therapy face almost 50% less risk of dying from cardiovascular disease than those who take insulin by multiple daily injections. The British Medical Journalhas published a study conducted at Sahlgrenska Academy.

Based on the National Diabetes Register, researchers monitored 18,168 Swedes with type 1 diabetes from 2005 to 2012. While 2,441 of the subjects used insulin pump therapy, the others relied on multiple daily injections.

Lower risk 

The study found that insulin pump users had a substantially lower risk of dying of cardiovascular disease than the daily injection group. The correlation was statistically certain.

"We carefully analyzed the findings to eliminate the risk of bias or confounding and concluded that the effect had been fully verified," says Isabelle Steineck, researcher at Sahlgrenska Academy.

More frequent monitoring 

The next step will be to identify the mechanisms that explain the extra benefits of insulin pump therapy. Dr. Steineck believes that one reason for the difference between the two therapies is that the insulin pump method is accompanied by more extensive patient training and more frequent blood glucose monitoring.

"There is a rationale for insulin pump treatment resulting in more stable blood glucose concentrations than multiple daily injections" she says. "Previous studies have shown that insulin pump can reduce the frequencies of severe hypoglycemic episodes. Severe hypoglycaemia can be a risk factor for cardiovascular events, particularly among high risk individuals."

"We evaluated the patients who used insulin pump therapy and do not know if the observed effect is attributable to continuous infusion of insulin or that some of the effect is attributable to intensified glucose monitoring, increased motivation to control blood glucose, or a better knowledge about having diabetes type 1" says Isabelle Steineck.

Safe and effective 

The researchers have concluded that insulin pumps not only make life easier for patients, but represent a safe and effective treatment method.

"This is good news for anyone with type 1 diabetes," says Soffia Gudbjörnsdottir, diabetologist and director of the Swedish National Diabetes Register. "But not everybody wants to use a pump, and the biggest priority is still to optimize blood glucose monitoring."

Approximately 20% of Swedish type 1 diabetes patients have access to insulin pump therapy. But earlier studies at Sahlgrenska Academy have demonstrated that hospitals vary greatly -- anywhere from 12% to almost 30% of patients may receive pumps.

http://www.sciencedaily.com/releases/2015/08/150811092042.htm

http://www.bmj.com/content/350/bmj.h3234

e-max.it: your social media marketing partner
 
Medtronic acquire Diabeter PDF Print E-mail

diabeter medtronic

Medtronic acquire Diabeter

Screen Shot 2015-08-15 at 15.14.44"The Diabeter acquisition is a milestone for Medtronic and for the Diabetes Group," said Hooman Hakami, executive vice president and president of the Diabetes Group at Medtronic. "This acquisition marks Medtronic's first entry into a diabetes integrated care model approach and signifies that Medtronic Diabetes is more than pumps and sensors - we are a holistic diabetes management company focused on making a real difference in outcomes and cost."

As one of the largest independent diabetes specialist centers for type 1 pediatrics and young adults in Europe, Diabeter currently manages over 1,500 patients and is recognized as a top center for diabetes care and clinical research. The team of 36 people at 4 locations practices personalized medicine making use of specially developed technologies, such as the Diabeter Dashboard, an electronic system that links patient and physician to encourage self-management with diabetes care team support. Internal Diabeter data shows that their patients have achieved significant reductions in HbA1c levels, a key measurement used to assess blood glucose control. Near normal blood glucose control has been show to reduce long-term complications of diabetes and can reduce healthcare costs over the long term.

"Diabeter has been pioneering this type of integrated care in the Netherlands, and we believe this approach can be applied more broadly to serve more patients, in more places around the world," said Henk Veeze, M.D., Ph.D., senior international medical director, Diabeter. "We have developed a unique system with improved clinical outcomes, combining outstanding clinical care with devices and information technology."

2nd April 2015 - Full Press Release

The company’s goal is to serve 20 million patients with diabetes by 2020, an approximate 20-fold increase from its current worldwide patient base of ~700,000. - See more at: www.diatribe.org

Diabeter website

e-max.it: your social media marketing partner
 
A Mile in My Shoes PDF Print E-mail

a type1 guide to the universeNEW - iBook by Joe Solowiejczyk - A Type 1 Diabetes Guide To The Universe  is available now on iTunes.  

A Type 1 Diabetes Guide to the Universe introduces a new way to learn to thrive with diabetes. It is the first book to integrate the psychological and emotional aspects of dealing with diabetes into the core of its approach, and it makes use of the most current and creative e-publishing tools available to give you a rich resource to read, interact with and hear all sorts of information that will help you and your family.

Additionally, A Mile in My Shoes is dedicated to producing fun, unique web-based presentations and learning resources for patients and their families wishing to increase their self-management knowledge base and emotional coping skills. The new e-book self-management manual, A Type 1 Diabetes Guide to the Universe, is a new and exciting part of that initiative. Visit A mile in My shoes Website here.

e-max.it: your social media marketing partner
 
Friends for Life Children with diabetes FFL 2015 PDF Print E-mail

Children with Diabetes, Friends for Life - International Conference and Expo

30th October - 1st November, 2015

Sold out!

Beaumont House Hotel and Conference Venue, Old Windsor, Berkshire, England

Registration will open in February for FFL in Windsor this year.

Contact Laura to be added to the waiting list.

CWD are always looking for sponsors to enable them to increase capacity, please get in touch with Laura if you have any ideas, suggestions or connections.

This e-mail address is being protected from spambots. You need JavaScript enabled to view it

For more information visit: www.childrenwithdiabetes.com/activities/UK2015

Friends for Life UK Children with Diabetes

e-max.it: your social media marketing partner
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Page 1 of 11